139 related articles for article (PubMed ID: 26423805)
1. Effect of rituximab on adult Burkitt's lymphoma: a systematic review and meta-analysis.
Nie M; Wang Y; Bi XW; Xia Y; Sun P; Liu PP; Li ZM; Jiang WQ
Ann Hematol; 2016 Jan; 95(1):19-26. PubMed ID: 26423805
[TBL] [Abstract][Full Text] [Related]
2. [Clinical and prognostic analysis of 186 children with Burkitt's lymphoma].
Zhang M; Jin L; Yang J; Duan YL; Huang S; Zhou CJ; Zhang YH
Zhonghua Er Ke Za Zhi; 2018 Aug; 56(8):605-610. PubMed ID: 30078243
[No Abstract] [Full Text] [Related]
3. [Long-term clinical outcome of children and adolescents with Burkitt's lymphoma treated with rituximab combined with modified NHL-BFM-90 regimen].
Li YX; Yin QS; Ai H; Mi RH; Zhang LN; Li YF; Wei XD; Song YP
Zhonghua Yi Xue Za Zhi; 2019 Feb; 99(8):605-610. PubMed ID: 30818930
[No Abstract] [Full Text] [Related]
4. [Clinical features and prognosis of children with Burkitt's lymphoma: an analysis of 62 cases].
Wang YC; DU WC; Yin CY; Gong X; Li YF
Zhongguo Dang Dai Er Ke Za Zhi; 2022 May; 24(5):561-565. PubMed ID: 35644197
[TBL] [Abstract][Full Text] [Related]
5. Adding rituximab to CODOX-M/IVAC chemotherapy in the treatment of HIV-associated Burkitt lymphoma is safe when used with concurrent combination antiretroviral therapy.
Alwan F; He A; Montoto S; Kassam S; Mee M; Burns F; Edwards S; Wilson A; Tenant-Flowers M; Marcus R; Ardeshna KM; Bower M; Cwynarski K
AIDS; 2015 May; 29(8):903-10. PubMed ID: 25730506
[TBL] [Abstract][Full Text] [Related]
6. [Therapy for Burkitt's lymphoma according to the BL-M-04 protocol: 12-year experience].
Baryakh EA; Tyurina NG; Vorobyev VI; Gemdzhyan EG; Mangasarova YK; Klyasova GA; Kovrigina AM; Obukhova TN; Zvonkov EE; Vernyuk MA; Chervontseva AM; Polyakov YY; Misyurina АЕ; Valiev TT; Zherebtsova VA; Magomedova AU; Galstyan GM; Yatskov KV; Nesterova ES; Vorobyev AI; Kravchenko SK
Ter Arkh; 2015; 87(7):4-14. PubMed ID: 26390720
[TBL] [Abstract][Full Text] [Related]
7. Rituximab maintenance for the treatment of patients with follicular lymphoma: systematic review and meta-analysis of randomized trials.
Vidal L; Gafter-Gvili A; Leibovici L; Dreyling M; Ghielmini M; Hsu Schmitz SF; Cohen A; Shpilberg O
J Natl Cancer Inst; 2009 Feb; 101(4):248-55. PubMed ID: 19211444
[TBL] [Abstract][Full Text] [Related]
8. Primary ovarian Burkitt's lymphoma: a rare oncological problem in gynaecology: a review of literature.
Stepniak A; Czuczwar P; Szkodziak P; Wozniakowska E; Wozniak S; Paszkowski T
Arch Gynecol Obstet; 2017 Oct; 296(4):653-660. PubMed ID: 28770352
[TBL] [Abstract][Full Text] [Related]
9. Effect of rituximab on primary central nervous system lymphoma: a meta-analysis.
Song Y; Wen Y; Xue W; Zhang Y; Zhang M
Int J Hematol; 2017 Nov; 106(5):612-621. PubMed ID: 28900847
[TBL] [Abstract][Full Text] [Related]
10. Rituximab combined with autologous peripheral blood stem cell transplantation improve therapeutic effects of chemotherapy in pediatric patients with Burkitt's lymphoma.
Li Y; Huang S; Wang X; Zhou D; Huang K; Guo H; Fang J; Chen C; Liu Q
J Trop Pediatr; 2010 Oct; 56(5):337-41. PubMed ID: 20065046
[TBL] [Abstract][Full Text] [Related]
11. Rituximab for the first-line treatment of stage III-IV follicular lymphoma (review of Technology Appraisal No. 110): a systematic review and economic evaluation.
Papaioannou D; Rafia R; Rathbone J; Stevenson M; Buckley Woods H; Stevens J
Health Technol Assess; 2012; 16(37):1-253, iii-iv. PubMed ID: 23021127
[TBL] [Abstract][Full Text] [Related]
12. Anthracycline-containing regimens for treatment of follicular lymphoma in adults.
Itchaki G; Gafter-Gvili A; Lahav M; Vidal L; Raanani P; Shpilberg O; Paul M
Cochrane Database Syst Rev; 2013 Jul; (7):CD008909. PubMed ID: 23832787
[TBL] [Abstract][Full Text] [Related]
13. Rituximab treatment strategy for patients with diffuse large B-cell lymphoma after first-line therapy: a systematic review and meta-analysis.
Ren YR; Jin YD; Zhang ZH; Li L; Wu P
Chin Med J (Engl); 2015 Feb; 128(3):378-83. PubMed ID: 25635435
[TBL] [Abstract][Full Text] [Related]
14. Rituximab-combination chemotherapy achieves a 10th cycle of remission for Burkitt's lymphoma.
Umeda K; Fujino H; Saida S; Kato I; Hiramatsu H; Yamada T; Hori T; Adachi S; Heike T; Watanabe K
Pediatr Int; 2015 Apr; 57(2):e30-3. PubMed ID: 25868956
[TBL] [Abstract][Full Text] [Related]
15. High-dose therapy with autologous stem cell transplantation versus chemotherapy or immuno-chemotherapy for follicular lymphoma in adults.
Schaaf M; Reiser M; Borchmann P; Engert A; Skoetz N
Cochrane Database Syst Rev; 2012 Jan; 1():CD007678. PubMed ID: 22258971
[TBL] [Abstract][Full Text] [Related]
16. Durable remission induced by rituximab-containing chemotherapy in a patient with primary refractory Burkitt's lymphoma.
Yokohama A; Tsukamoto N; Uchiumi H; Handa H; Matsushima T; Karasawa M; Murakami H; Nojima Y
Ann Hematol; 2004 Feb; 83(2):120-3. PubMed ID: 14513289
[TBL] [Abstract][Full Text] [Related]
17. Immunochemotherapy with rituximab and overall survival in patients with indolent or mantle cell lymphoma: a systematic review and meta-analysis.
Schulz H; Bohlius JF; Trelle S; Skoetz N; Reiser M; Kober T; Schwarzer G; Herold M; Dreyling M; Hallek M; Engert A
J Natl Cancer Inst; 2007 May; 99(9):706-14. PubMed ID: 17470738
[TBL] [Abstract][Full Text] [Related]
18. Rituximab is highly effective in children and adolescents with Burkitt lymphoma in Risk Groups R2 to R4.
Zhen Z; Zhu J; Wang J; Lu S; Sun F; Huang J; Sun X
Pediatr Hematol Oncol; 2020 Sep; 37(6):489-499. PubMed ID: 32364412
[TBL] [Abstract][Full Text] [Related]
19. Strategies to overcome myelotoxic therapy for the treatment of Burkitt's and AIDS-related non-Hodgkin's lymphoma.
Rochford R; Feuer G; Orem J; Banura C; Katongole-Mbidde E; Mwanda WO; Moormann A; Harrington WJ; Remick SC
East Afr Med J; 2005 Sep; 82(9 Suppl):S155-60. PubMed ID: 16619692
[TBL] [Abstract][Full Text] [Related]
20. Prognostic values of interim and post-therapy 18F-FDG PET/CT scanning in adult patients with Burkitt's lymphoma.
Wei WX; Huang JJ; Li WY; Zhang X; Xia Y; Jiang WQ; Fan W; Li ZM
Chin J Cancer; 2015 Dec; 34(12):608-13. PubMed ID: 26630874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
